New Jersey Regenerative Institute
- PRP Therapy
- Shockwave Therapy
- Ozone Therapy
- Oxygen Therapy
- Arthritis Treatment
Parsippany, NJ
Stem Cell Therapy consult rooms in Parsippany NJ sit along Route 46 / Parsippany Rd medical corridor, I-80 Parsippany exits, and Morris Plains / Troy Hills drive-time suites, more than spa calendars. Local Stem Cell Therapy clinics pack cash-pay menus between primary-care referrals and drive-time longevity pitches aimed at metro and suburb patients alike. A neighboring suburb commute changes who books follow-up, not the dosing math. This hub is Parsippany NJ listings, not Morristown or Newark paste.
Stem cell therapy is not one product. Source tissue, processing claims, guidance imaging, and follow-up plans all change what you buy. A lobby claim of "stem cell regeneration" is marketing until you see the written protocol and consent language.
This hub lists Directory clinics for Parsippany NJ and Stem Cell Therapy. Inclusion is not an endorsement. Listing order is not paid ranking. Regenerated.com is free for patients. Featured slots stay labeled; Verified means credential checks, not spend.
Ask which tissue source they claim, how processing is documented, whether imaging guides the procedure, what infection and clotting risks they screen, and what happens if symptoms do not match the brochure. Local freeways shape booking windows, not the underlying biology. Prefer plain risk talk and written consent. Use the national Stem Cell Therapy Directory and Guide, then return here.
Before you trust badges and counts on this page, read How to read a Regenerated city hub and Featured vs Verified vs organic. Then return here for local listings.
Regulatory context
New Jersey cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in New Jersey for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. New Jersey has a substantial pharmaceutical and biotech presence with both compliant industry programs and direct-to-patient clinics.
The FDA has issued warning letters to New Jersey clinics offering stem cell and exosome therapies. The New Jersey State Board of Medical Examiners has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The New Jersey Division of Consumer Affairs and Attorney General have used the New Jersey Consumer Fraud Act to pursue clinics making unsupported clinical claims; the NJCFA enables treble damages and attorney fees, raising the financial stakes for noncompliance. Class actions against regenerative providers have produced settlements.
Available here
Nationwide
Stem Cell Therapy clinics across the US